chr2-232486228-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004826.4(ECEL1):c.426C>A(p.Asp142Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 1,601,354 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004826.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ECEL1 | NM_004826.4 | c.426C>A | p.Asp142Glu | missense_variant | 2/18 | ENST00000304546.6 | |
ECEL1 | NM_001290787.2 | c.426C>A | p.Asp142Glu | missense_variant | 2/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ECEL1 | ENST00000304546.6 | c.426C>A | p.Asp142Glu | missense_variant | 2/18 | 1 | NM_004826.4 | P4 | |
ECEL1 | ENST00000409941.1 | c.426C>A | p.Asp142Glu | missense_variant | 1/17 | 1 | A1 | ||
ECEL1 | ENST00000482346.1 | n.630C>A | non_coding_transcript_exon_variant | 2/17 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00873 AC: 1329AN: 152218Hom.: 9 Cov.: 34
GnomAD3 exomes AF: 0.00798 AC: 1802AN: 225814Hom.: 11 AF XY: 0.00782 AC XY: 982AN XY: 125558
GnomAD4 exome AF: 0.0104 AC: 15082AN: 1449026Hom.: 110 Cov.: 32 AF XY: 0.0102 AC XY: 7373AN XY: 721226
GnomAD4 genome AF: 0.00873 AC: 1330AN: 152328Hom.: 9 Cov.: 34 AF XY: 0.00924 AC XY: 688AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | ECEL1: BS1, BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2020 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 07, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at